Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference RBC Capital Markets Global Healthcare Conference 2013 Business Wire JERUSALEM -- February 25, 2013 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 2013 RBC Capital Markets Global Healthcare Conference. Jon Congleton, SVP, Global Medicines Group, will present on Wednesday, February 27, 2013. What: Teva Presentation at the 2013 RBC Capital Markets Global Healthcare Conference Who: Jon Congleton, SVP, Global Medicines Group When: Wednesday, February 27 2013 at 1:30 PM (EST) Where: www.tevapharm.com or http://www.veracast.com/webcasts/rbc/healthcare2013/38211345.cfm How: Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012. Contact: Teva Pharmaceutical Industries Ltd. IR: Kevin C. Mannix United States 215-591-8912 or Kristen Frank United States 215-591-8908 or Tomer Amitai Israel 972 (3) 926-7656 or PR: Hadar Vismunski-Weinberg Israel 972 (3) 926-7687 or Denise Bradley United States 215-591-8974
Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.